Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-020187
Filing Date
2018-03-16
Accepted
2018-03-16 16:31:43
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4465
  Complete submission text file 0001209191-18-020187.txt   6150
Mailing Address 325 CENTRAL PARK W APT 38 NEW YORK NY 10025
Business Address
SCHEINBERG DAVID A (Reporting) CIK: 0001250316 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33958 | Film No.: 18696012

Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations